Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Exchange Rate Effect (2016 - 2025)

Sunshine Biopharma (SBFM) has disclosed Exchange Rate Effect for 11 consecutive years, with -$228322.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 129.56% year-over-year to -$228322.0, compared with a TTM value of $505165.0 through Sep 2025, up 459.39%, and an annual FY2023 reading of $534258.0, up 49798.42% over the prior year.
  • Exchange Rate Effect was -$228322.0 for Q3 2025 at Sunshine Biopharma, down from $325487.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $772282.0 in Q3 2024 and bottomed at -$1.3 million in Q2 2024.
  • Average Exchange Rate Effect over 5 years is $38130.0, with a median of $528.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect tumbled 3301.9% in 2021, then soared 3768.23% in 2023.
  • Year by year, Exchange Rate Effect stood at -$20268.0 in 2021, then skyrocketed by 615.8% to $104542.0 in 2022, then skyrocketed by 376.66% to $498306.0 in 2023, then decreased by 18.12% to $408000.0 in 2024, then crashed by 155.96% to -$228322.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for SBFM at -$228322.0 in Q3 2025, $325487.0 in Q2 2025, and $408000.0 in Q4 2024.